Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2

AUTOR(ES)

Jaiswal, Smita

FONTE

American Society for Microbiology

RESUMO

A recombinant replication-defective adenovirus vector that can overexpress the ectodomain of the envelope protein of dengue virus type 2 (NGC strain) has been constructed. This virus was immunogenic in mice and elicited dengue virus type 2 specific B- and T-cell responses. Sera from immunized mice contained neutralizing antibodies that could specifically recognize dengue virus type 2 and neutralize its infectivity in vitro, indicating that this approach has the potential to confer protective immunity. In vitro stimulation of splenocytes (from immunized mice) with dengue virus type 2 resulted in a significant proliferative response accompanied by the production of high levels of gamma interferon but did not show significant changes in interleukin-4 levels. This is suggestive of a Th1-like response (considered to be important in the maturation of cytotoxic T lymphocytes that are essential for the elimination of virus-infected cells). The data show that adenovirus vectors offer a promising alternative strategy for the development of dengue virus vaccines.

Documentos Relacionados

• Replication-Defective Bovine Adenovirus Type 3 as an Expression Vector†
• Gene targeting with a replication-defective adenovirus vector.
• Replication-Defective Vector Based on a Chimpanzee Adenovirus
• Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.
• RNA of replication-defective strains of Rous sarcoma virus.